Alto Neuroscience
ANRO
ANRO
77 hedge funds and large institutions have $95.3M invested in Alto Neuroscience in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1.55% less ownership
Funds ownership: 85.09% → 83.54% (-1.5%)
48% less call options, than puts
Call options by funds: $136K | Put options by funds: $260K
64% less capital invested
Capital invested by funds: $265M → $95.3M (-$170M)
Holders
77
Holding in Top 10
2
Calls
$136K
Puts
$260K
Top Buyers
| 1 | +$4.13M | |
| 2 | +$3.54M | |
| 3 | +$3.02M | |
| 4 |
AC
Armistice Capital
New York
|
+$2.75M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$2.1M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$13.3M | |
| 3 | -$9.52M | |
| 4 |
PFMOSF
Philadelphia Financial Management of San Francisco
San Francisco,
California
|
-$5.15M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.64M |